At the news
? NEUTRALIMPACT 3/10 8-K filed Sep 3, 2026 at 07:07 ET
Profound Medical appointed Richard Fabian as President, effective September 1, 2026, succeeding Mathieu Burtnyk who moved to the newly created Chief Technology Officer role. Fabian brings deep medical device and imaging leadership from FUJIFILM Sonosite and Philips Healthcare. This is a routine executive restructuring with no financial data or guidance provided, making it a neutral event for traders.
- Richard Fabian appointed President effective September 1, 2026
- Mathieu Burtnyk shifted to newly created Chief Technology Officer role
- Fabian previously President and CEO of FUJIFILM Sonosite (2017-2026) and held executive roles at Philips Healthcare
- Employment agreement: $550,000 annual base salary, up to 100% bonus, 200,000 RSUs (3-year vest), options for 475,000 shares (4-year vest)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access